Heme oxygenase 1 overexpression induces immune evasion of acute myeloid leukemia against natural killer cells by inhibiting CD48

被引:0
|
作者
Tianzhuo Zhang
Qin Fang
Ping Liu
Ping Wang
Cheng Feng
Jishi Wang
机构
[1] Guizhou Medical University,Department of Clinical Medical School
[2] Affiliated Hospital of Guizhou Medical University,Department of Hematology
[3] Department of Guizhou Province Hematopoietic Stem Cell Transplantation Center and Key Laboratory of Hematological Disease Diagnostic and Treatment Centre,Department of Pharmacy
[4] Affiliated Hospital of Guizhou Medical University,undefined
关键词
Acute myeloid leukemia; Heme oxygenase 1; Natural killer cells; CD48; Sirt1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] EX VIVO GENERATION OF CLINICALLY RELEVANT AMOUNTS OF HUMAN NATURAL KILLER CELLS FOR IMMUNOTHERAPY AGAINST ACUTE MYELOID LEUKEMIA
    Spanholtz, J.
    Tordoir, M.
    De Witte, T.
    Dolstra, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 240 - 240
  • [22] Adoptively Infused Memory-like Natural Killer Cells Impact Adaptive Immune Responses in Patients with Acute Myeloid Leukemia
    Rutella, Sergio
    Vadakekolathu, Jayakumar
    Cashen, Amanda F.
    Mahajan, Nitin
    Ruiz-Heredia, Yanira
    Martin-Munoz, Alejandro
    Barrio, Santiago
    Berrien-Elliott, Melissa M.
    Davidson-Moncada, Jan
    Fehniger, Todd A.
    BLOOD, 2023, 142
  • [23] T-cell-receptor redirected CD3+natural killer cells for adoptive immunotherapy to acute myeloid leukemia
    Wernersbach, J.
    Khan, S. A.
    Theobald, M.
    Hartwig, U. F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 233 - 233
  • [24] Heme oxygenase-1 suppresses the apoptosis of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway
    Lin, Xiaojing
    Fang, Qin
    Chen, Shuya
    Zhe, Nana
    Chai, Qixiang
    Yu, Meisheng
    Zhang, Yaming
    Wang, Ziming
    Wang, Jishi
    LEUKEMIA RESEARCH, 2015, 39 (05) : 544 - 552
  • [25] Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia
    Kaito, Yuta
    Sugimoto, Emi
    Nakamura, Fumi
    Tsukune, Yutaka
    Sasaki, Makoto
    Yui, Shunsuke
    Yamaguchi, Hiroki
    Goyama, Susumu
    Nannya, Yasuhito
    Mitani, Kinuko
    Tamura, Hideto
    Imai, Yoichi
    HAEMATOLOGICA, 2024, 109 (04) : 1107 - 1120
  • [26] Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia
    Kaito, Yuta
    Sugimoto, Emi
    Nakamura, Fumi
    Tsukune, Yutaka
    Sasaki, Makoto
    Yui, Shunsuke
    Yamaguchi, Hiroki
    Goyama, Susumu
    Nannya, Yasuhito
    Mitani, Kinuko
    Tamura, Hideto
    Imai, Yoichi
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 1107 - 1120
  • [27] CD33 expression on natural killer cells is a potential confounder for residual disease detection in acute myeloid leukemia by flow cytometry
    Eckel, Ashley M.
    Cherian, Sindhu
    Miller, Valerie
    Soma, Lorinda
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2020, 98 (02) : 174 - 178
  • [28] Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells
    Langenkamp, Ulrich
    Siegler, Uwe
    Joerger, Simon
    Diermayr, Stefan
    Gratwohl, Alois
    Kalberer, Christian P.
    Wodnar-Filipowicz, Aleksandra
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (11): : 1590 - 1594
  • [29] CD70 targeting bi-specific Natural Killer cell Engager (BIKE) eliminate acute myeloid leukemia cells
    Boy, M.
    Bratschi, H.
    Riether, C.
    Ochsenbein, A.
    SWISS MEDICAL WEEKLY, 2023, 153 : 5S - 6S
  • [30] Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice
    U Siegler
    C P Kalberer
    P Nowbakht
    S Sendelov
    S Meyer-Monard
    A Wodnar-Filipowicz
    Leukemia, 2005, 19 : 2215 - 2222